Potent dual 5-lipoxygenase inhibitor and PAF receptor antagonist

被引：0
|
作者：
Lloyd, AW [1 ]
机构：
[1] Univ Brighton, Dept Pharm, Brighton BN2 4GJ, E Sussex, England
来源：
DRUG DISCOVERY TODAY | 1998年 / 3卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：424 / 424
页数：1
相关论文
共 50 条
  • [41] Development of CMI-977 as a potent and orally active 5-lipoxygenase inhibitor.
    Cai, X
    Cheah, S
    Chen, SM
    Eckman, J
    Ellis, J
    Fisher, R
    Fura, A
    Grewal, G
    Hussion, S
    Ip, S
    Killian, DB
    LibertineGarahan, L
    Lounsbury, H
    Qian, CG
    Scannell, RT
    Yaeger, D
    Wypij, DM
    Yeh, CG
    Young, MA
    Yu, SX
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 214 - MEDI
  • [42] P-8977 - A TOPICALLY EFFECTIVE DUAL 5-LIPOXYGENASE CYCLOOXYGENASE INHIBITOR
    TEGELER, JJ
    KURTZ, ELS
    MADDALENA, ME
    HELLYER, L
    FREED, BS
    HAMER, RRL
    MARTIN, LL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 1 - MEDI
  • [43] Effects of dual inhibitor of cyclooxygenase and 5-lipoxygenase on acute necrotizing pancreatitis in rats
    Kalyoncu, Nuri I.
    Alhan, Etem
    Ercin, Cengiz
    Kural, Birgul Vanizor
    HEPATO-GASTROENTEROLOGY, 2006, 53 (70) : 597 - 602
  • [44] THE EFFECTS OF A 5-LIPOXYGENASE INHIBITOR, BW A4C, ON THE ACUTE RESPONSE TO INHALED PAF IN MAN
    SPENCER, DA
    SAMPSON, AP
    EVANS, JM
    GARLAND, LG
    PIPER, PJ
    COSTELLO, JF
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 629 : 430 - 431
  • [45] UCB 62045 - Pharmacology of a novel, dual-function anti-inflammatory agent with histamine type 1 receptor antagonist and 5-lipoxygenase inhibitor activity
    Selig, WM
    Bayless, L
    Libertine, L
    Eckman, JB
    Wypij, DM
    Wels, BF
    Eckert, M
    Young, MA
    Nicolas, JM
    Scannell, RT
    Ellis, JL
    CHEST, 2003, 123 (03) : 371S - 371S
  • [46] RBx 7796: A novel inhibitor of 5-lipoxygenase
    R. K. Shirumalla
    K. S. Naruganahalli
    S. G. Dastidar
    V. Sattigeri
    G. Kaur
    C. Deb
    J. B. Gupta
    M. Salman
    A. Ray
    Inflammation Research, 2006, 55 : 517 - 527
  • [47] 5-Lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci
    Tantisira, Kelan G.
    Lima, John
    Sylvia, Jody
    Klanderman, Barbara
    Weiss, Scott T.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (03): : 244 - 247
  • [48] RBx 7796: A novel inhibitor of 5-lipoxygenase
    Shirumalla, R. K.
    Naruganahalli, K. S.
    Dastidar, S. G.
    Sattigeri, V.
    Kaur, G.
    Deb, C.
    Gupta, J. B.
    Salman, M.
    Ray, A.
    INFLAMMATION RESEARCH, 2006, 55 (12) : 517 - 527
  • [49] Protection of dopaminergic neurons by 5-lipoxygenase inhibitor
    Kang, Kai-Hsiang
    Liou, Horng-Hui
    Hour, Mann-Jen
    Liou, Houng-Chi
    Fu, Wen-Mei
    NEUROPHARMACOLOGY, 2013, 73 : 380 - 387
  • [50] TOTAL SYNTHESIS OF ARDISIAQUINONE-A, A POTENT 5-LIPOXYGENASE INHIBITOR, ISOLATED FROM ARDISIA-SIEBOLDII, AND DEGREE OF 5-LIPOXYGENASE INHIBITORY ACTIVITY OF ITS DERIVATIVES
    FUKUYAMA, Y
    KIRIYAMA, Y
    KODAMA, M
    IWAKI, H
    HOSOZAWA, S
    AKI, S
    MATSUI, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (10) : 2211 - 2213
12345